Joe Y. Chang

27.7k total citations · 4 hit papers
353 papers, 14.0k citations indexed

About

Joe Y. Chang is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joe Y. Chang has authored 353 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 285 papers in Pulmonary and Respiratory Medicine, 151 papers in Radiation and 120 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joe Y. Chang's work include Lung Cancer Diagnosis and Treatment (201 papers), Advanced Radiotherapy Techniques (151 papers) and Lung Cancer Treatments and Mutations (89 papers). Joe Y. Chang is often cited by papers focused on Lung Cancer Diagnosis and Treatment (201 papers), Advanced Radiotherapy Techniques (151 papers) and Lung Cancer Treatments and Mutations (89 papers). Joe Y. Chang collaborates with scholars based in United States, China and Canada. Joe Y. Chang's co-authors include Ritsuko Komaki, Zhongxing Liao, James D. Cox, Radhe Mohan, James W. Welsh, Peter Balter, Pamela K. Allen, Ritsuko Komaki, Xiaodong Zhang and Daniel R. Gomez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Joe Y. Chang

344 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy

2005 473 citations Radhe Mohan, Joe Y. Chang et al. profile →
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

2015 463 citations Joe Y. Chang et al. profile →
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials

2020 353 citations Joe Y. Chang, Patricia M. de Groot et al. profile →
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

2015 302 citations Chen Hu, Joe Y. Chang et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Joe Y. Chang

Since Specialization

Citations

This map shows the geographic impact of Joe Y. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe Y. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe Y. Chang more than expected).

Fields of papers citing papers by Joe Y. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe Y. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe Y. Chang. The network helps show where Joe Y. Chang may publish in the future.

Co-authorship network of co-authors of Joe Y. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Joe Y. Chang. A scholar is included among the top collaborators of Joe Y. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe Y. Chang. Joe Y. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Li G, (unknown), (unknown), Joe Y. Chang, Hanbo Chen, Ian Poon, (unknown), May Tsao, Yee Ung, Patrick Cheung, Alexander V. Louie	3
2	Management of Central Airway Obstruction 2024 ·CHEST Journal ·Kamran Mahmood, Lindsy Frazer-Green, Anne V. Gonzalez, Scott Shofer, A. Christine Argento, Ian J. Welsby, Russell K. Hales, Samira Shojaee, Donna D. Gardner, Joe Y. Chang, Felix Herth, (unknown)	5
3	Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer 2024 ·Cancers ·Matthew S. Ning, (unknown), Joe Y. Chang, Saumil Gandhi, Zhongxing Liao, Steven H. Lin, Aileen B. Chen, James W. Welsh, Quynh‐Nhu Nguyen, Michael S. O’Reilly, Stephen G. Chun, Julianna Bronk, David C. Qian, Percy Lee	2
4	Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial 2023 ·Anticancer Research ·(unknown), Mike Hernández, Joe Y. Chang, Steven H. Lin, Zhongxing Liao, (unknown), Heath D. Skinner, Stephen G. Chun	1
5	The Inherited KRAS -variant as a Biomarker of Cetuximab Response in NSCLC 2023 ·Cancer Research Communications ·Joanne B. Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein, Joe Y. Chang, (unknown), Adam P. Dicker, Jeffrey A. Bogart, Yolanda I. Garces, Samir Narayan, Clifford G. Robinson, Vivek S. Kavadi, Joel S. Greenberger, Christopher D. Koprowski, James W. Welsh, Elizabeth Gore, Robert M. MacRae, Rebecca Paulus, Jeffrey D. Bradley	1
6	SwarmDeepSurv: swarm intelligence advances deep survival network for prognostic radiomics signatures in four solid cancers 2023 ·Patterns ·Qasem Al-Tashi, Maliazurina B. Saad, Ajay Sheshadri, Carol C. Wu, Joe Y. Chang, Bissan Al‐Lazikani, Christopher Gibbons, Natalie I. Vokes, Jianjun Zhang, J. Jack Lee, John V. Heymach, David A. Jaffray, Seyedali Mirjalili, Jia Wu	4
7	Proton Single-Energy Bragg-Peak FLASH Using Clinical Systems Can Achieve IMPT-Equivalent Plan Quality for Breast and Prostate Cancers 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Chih-Chun Cheng, Shaakir Hasan, (unknown), Charles B. Simone, Haibo Lin, Minglei Kang, Joe Y. Chang	1
8	Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer 2021 ·Clinical Lung Cancer ·David Boyce-Fappiano, Quynh‐Nhu Nguyen, Bhavana V. Chapman, Pamela K. Allen, Olsi Gjyshi, Todd A. Pezzi, Brian De, Daniel R. Gomez, Steven H. Lin, Joe Y. Chang, Zhongxing Liao, Percy Lee, Saumil Gandhi	14
9	Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model 2018 ·Clinical Cancer Research ·Sharareh Niknam, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, (unknown), Niranjan Yanamandra, Mauricio S. Caetano, Ailin Li, Ahmed Younes, Alexandra P. Cadena, Taylor R. Cushman, Joe Y. Chang, Q.N. Nguyen, Daniel R. Gomez, Adi Diab, John V. Heymach, Patrick Hwu, María Angélica Cortez, James W. Welsh	46
10	Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells 2016 ·Clinical Cancer Research ·Chad Tang, James W. Welsh, Patricia M. de Groot, Erminia Massarelli, Joe Y. Chang, Kenneth R. Hess, Sreyashi Basu, Michael A. Curran, Maria E. Cabanillas, Vivek Subbiah, Siqing Fu, Apostolia M. Tsimberidou, Daniel D. Karp, Daniel R. Gomez, Adi Diab, Ritsuko Komaki, John V. Heymach, Padmanee Sharma, Aung Naing, David S. Hong	251
11	A Phase III Randomized Study of Image Guided Conventional (60 Gy/30 fx) Versus Accelerated, Hypofractionated (60 Gy/15 fx) Radiation for Poor Performance Status Stage II and III NSCLC Patients—An Interim Analysis 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Puneeth Iyengar, Kenneth D. Westover, Laurence E. Court, Mehul Patel, (unknown), Mark W. Saunders, (unknown), Joe Y. Chang, Andrew Gao, Chul Ahn, H. Choy, Robert Timmerman	13
12	Motion‐robust intensity‐modulated proton therapy for distal esophageal cancer 2016 ·Medical Physics ·Jen Yu, Xiaodong Zhang, Li Liao, Heng Li, Ronald X. Zhu, Peter C. Park, Narayan Sahoo, Michael T. Gillin, Yupeng Li, Joe Y. Chang, Ritsuko Komaki, Steven H. Lin	56
13	What Is the Optimal SABA Dose for Local Control After Stereotactic Ablative Radiation Therapy in Lung Cancer: A 10 Year Experience of 1092 Patients 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Lina Zhao, Peter Balter, Daniel R. Gomez, James W. Welsh, Steven H. Lin, Joe Y. Chang	1
14	A Novel 4-D Robust Optimization Mitigates Interplay Effect in Intensity Modulated Proton Therapy for Lung Cancer 2015 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Steven E. Schild, Joe Y. Chang, Zhibin Liao, Jiajian Shen, Jaap Stoker, Zhifei Wen, William W. Wong, Narayan Sahoo, Michael Herman, Radhe Mohan, Martin Bues	4
15	Use of Emission Guided Radiation Therapy Can Better Spare Critical Structures Compared With Intensity Modulated Radiation Therapy, Volumetric Modulated Arc Therapy, or Proton Therapy 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Steven N. Seyedin, Osama Mawlawi, (unknown), (unknown), Yevgen Voronenko, Peter D. Olcott, (unknown), Peter Balter, Joe Y. Chang, Daniel R. Gomez, Ritsuko Komaki, James W. Welsh	1
16	Prospective Phase 1/2 Clinical Trial: Evaluating Dose-Escalation for Esophageal Cancer 2015 ·International Journal of Radiation OncologyBiologyPhysics ·James W. Welsh, Steven N. Seyedin, Wayne L. Hofstetter, Jaffer A. Ajani, Joe Y. Chang, Daniel R. Gomez, S.G. Swisher, Mariela A. Blum, Quynh Nguyen, Bruce D. Minsky, Jeremy J. Erasmus, Jang Hyun Lee, Manoop S. Bhutani, Ritsuko Komaki	2
17	SU‐F‐BRD‐01: A Novel 4D Robust Optimization Mitigates Interplay Effect in Intensity‐Modulated Proton Therapy for Lung Cancer 2015 ·Medical Physics ·(unknown), Steven E. Schild, Joe Y. Chang, Zhongxing Liao, Zhifei Wen, Jiajian Shen, Jaap Stoker, William W. Wong, Narayan Sahoo, Michael Herman, Radhe Mohan, Martin Bues	2
18	Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer 2013 ·Journal of Clinical Oncology ·James W. Welsh, Ritsuko Komaki, Arya Amini, Mark F. Munsell, (unknown), Pamela K. Allen, Joe Y. Chang, Jeffrey S. Wefel, Susan L. McGovern, Linda L. Garland, Su S. Chen, (unknown), Zhongxing Liao, Paul D. Brown, Erik P. Sulman, John V. Heymach, Edward S. Kim, Baldassarre Stea	314
19	Characterizing the interaction between radiation sensitivity and epidermal growth factor receptor inhibition in prostate cancer cell lines 2005 ·Cancer Research ·Rex Cheung, Xiaochun Zhang, (unknown), Bingliang Fang, Joe Y. Chang	0
20	Inhibition of intratracheal lung cancer development by systemic delivery of E1A. 1996 ·PubMed ·Joe Y. Chang, Weiya Xia, Ruping Shao, Mien‐Chie Hung	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact